Highland Capital Management LLC Raises Holdings in Lam Research Corporation $LRCX

Key Points

• Highland Capital Management increased its stake in Lam Research by 569.8% in Q4 and now owns 14,936 shares worth about $2.557 million, according to its latest 13F filing.
• Lam Research posted a March‑quarter revenue and EPS beat and gave an upbeat June‑quarter outlook, driving analyst upgrades and higher price targets (consensus target about $285.94) and pushing the stock toward its 52‑week high.
• Despite the strong results, notable selling was disclosed — insiders have sold 155,066 shares (~$35.85M) in the past 90 days, while institutional investors own about 84.61% of the stock.

Highland Capital Management LLC lifted its position in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 569.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,936 shares of the semiconductor company's stock after purchasing an additional 12,706 shares during the period. Highland Capital Management LLC's holdings in Lam Research were worth $2,557,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the company. Traphagen Investment Advisors LLC lifted its stake in shares of Lam Research by 2.4% in the 4th quarter. Traphagen Investment Advisors LLC now owns 1,963 shares of the semiconductor company's stock valued at $336,000 after purchasing an additional 46 shares during the period. Field & Main Bank grew its position in shares of Lam Research by 1.1% during the 4th quarter. Field & Main Bank now owns 4,615 shares of the semiconductor company's stock valued at $790,000 after acquiring an additional 50 shares during the period. Capital Advisors Ltd. LLC grew its position in shares of Lam Research by 1.1% during the 4th quarter. Capital Advisors Ltd. LLC now owns 4,646 shares of the semiconductor company's stock valued at $795,000 after acquiring an additional 51 shares during the period. Global Financial Private Client LLC grew its position in shares of Lam Research by 0.5% during the 4th quarter. Global Financial Private Client LLC now owns 11,037 shares of the semiconductor company's stock valued at $1,889,000 after acquiring an additional 52 shares during the period. Finally, WealthCollab LLC grew its position in shares of Lam Research by 29.3% during the 4th quarter. WealthCollab LLC now owns 243 shares of the semiconductor company's stock valued at $42,000 after acquiring an additional 55 shares during the period. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Earnings beat + bullish near‑term guide — Lam reported a March‑quarter revenue and EPS beat and gave an upbeat June‑quarter outlook, which the market interpreted as accelerating wafer‑fab demand and margin expansion. Lam Research jumps 7% as earnings beat and June-quarter outlook signals accelerating wafer-fab demand
• Positive Sentiment: TAM and secular demand lift the investment case — Analysts and commentators raised WFE and hyperscaler‑capex forecasts (Lam’s environment looks larger), reinforcing growth expectations and the claim that AI-driven device complexity benefits Lam’s etch/deposition exposure. Lam Research: $140B WFE, $725B In Hyperscaler Capex, And Still Raising -- BUY
• Positive Sentiment: Analyst target upgrades and bullish notes — Multiple firms have raised price targets and reiterated Outperform/Buy calls after the quarter, supporting momentum and upside thesis. Lam Research (LRCX) Surges to Record Highs: Analyzing the 252% Rally
• Positive Sentiment: Technical breakout / IBD recognition — The stock cleared an IBD buy point after the strong report, drawing momentum and retail/institutional interest. Lam Research, IBD Stock Of The Day, Clears Buy Point On Chip-Gear Investments
• Neutral Sentiment: Insider sale disclosed — An SVP sold ~18k shares under a pre‑arranged Rule 10b5‑1 plan; routine disclosure but worth noting for timing/context. Insider Selling: Lam Research NASDAQ: LRCX SVP Sells 18,170 Shares of Stock
• Neutral Sentiment: Valuation and “froth” commentary — Some analysis flags stretched multiples and consolidation risk after the run; elevated P/E requires investors to weigh growth vs. premium valuation. Lam Research Is Approaching Frothy Levels
• Negative Sentiment: Insider and institutional selling activity — Reports show multiple executive sales and notable institutional repositioning in recent quarters; while some are pre‑planned or rebalancing, sustained selling can temper sentiment if it continues. Lam Research jumps 7% as earnings beat and June-quarter outlook signals accelerating wafer-fab demand

Analysts Set New Price Targets

LRCX has been the topic of a number of analyst reports. Susquehanna raised their target price on Lam Research from $350.00 to $385.00 and gave the company a "positive" rating in a research report on Thursday, April 23rd. Citigroup restated a "buy" rating and set a $315.00 target price (up from $300.00) on shares of Lam Research in a research report on Thursday, April 23rd. Citic Securities raised their target price on Lam Research from $165.00 to $275.00 and gave the company a "buy" rating in a research report on Friday, January 30th. Weiss Ratings upgraded Lam Research from a "buy (b-)" rating to a "buy (b)" rating in a research report on Friday, April 24th. Finally, New Street Research boosted their price target on shares of Lam Research from $235.00 to $280.00 and gave the stock a "neutral" rating in a report on Monday, April 27th. Twenty-six investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat.com, Lam Research has an average rating of "Moderate Buy" and an average price target of $285.94.

Lam Research Stock Performance

LRCX opened at $275.80 on Wednesday. The company has a quick ratio of 1.77, a current ratio of 2.54 and a debt-to-equity ratio of 0.35. The company has a market cap of $344.91 billion, a price-to-earnings ratio of 52.04, a PEG ratio of 2.14 and a beta of 1.81. Lam Research Corporation has a 52-week low of $72.59 and a 52-week high of $280.00. The firm's fifty day simple moving average is $236.99 and its two-hundred day simple moving average is $202.86.

Lam Research (NASDAQ:LRCX - Get Free Report) last posted its quarterly earnings data on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.11. The business had revenue of $5.84 billion for the quarter, compared to the consensus estimate of $5.70 billion. Lam Research had a net margin of 30.94% and a return on equity of 66.21%. The company's revenue was up 23.8% compared to the same quarter last year. During the same period last year, the firm posted $1.04 earnings per share. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. Equities analysts anticipate that Lam Research Corporation will post 5.68 earnings per share for the current fiscal year.

Insider Buying and Selling at Lam Research

In other news, Director Eric Brandt sold 35,000 shares of the stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $225.60, for a total value of $7,896,000.00. Following the completion of the sale, the director directly owned 253,705 shares in the company, valued at $57,235,848. This represents a 12.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Douglas R. Bettinger sold 50,057 shares of the stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the completion of the sale, the chief financial officer owned 1,081,705 shares of the company's stock, valued at $242,334,371.15. This trade represents a 4.42% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 155,066 shares of company stock valued at $35,849,242 over the last ninety days. 0.31% of the stock is currently owned by corporate insiders.

Lam Research Profile

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.